Paper8093668
P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy.
Grogan TM and 7 others. Blood, 1993. Cited by 191 papers, by iCite.
Cite this record
ConductScience Library. P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy. Papers, record 8093668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8093668
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow | Major topic |
| Doxorubicin | Major topic |
| Membrane Glycoproteins | Major topic |
| Multiple Myeloma | Major topic |
| Vincristine | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Antibodies, Monoclonal | |
| Antigens, CD | |
| Biopsy | |
| Dose-Response Relationship, Drug | |
| Drug Resistance | |
| Female | |
| Humans | |
| Immunohistochemistry | |
| Immunophenotyping | |
| Male | |
| Middle Aged | |
| Neoplasm Staging | |
| Regression Analysis |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-17094 | NCI NIH HHS | United States | P01CA017094 | PubMed and NIH | NIH RePORTER |
| CA-23074 | NCI NIH HHS | United States | P30CA023074 | PubMed and NIH | NIH RePORTER |
| CA-43043 | NCI NIH HHS | United States | R01CA043043 | PubMed and NIH | NIH RePORTER |
| R23CA043043 | NIH | NIH RePORTER | |||
| R29CA043043 | NIH | NIH RePORTER |
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 191 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37686623 | Unlocking Drug Resistance in Multiple Myeloma: Adipocytes as Modulators of Treatment Response. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37686623 | PubMed |
| 36678608 | Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/36678608 | PubMed |
| 36325145 | P-glycoprotein and cancer: what do we currently know? | Heliyon | 2022 | https://conductscience.org/library/papers/36325145 | PubMed |
| 35582143 | Resistance to anti-tubulin agents: From vinca alkaloids to epothilones. | Cancer Drug Resist | 2019 | https://conductscience.org/library/papers/35582143 | PubMed |
| 35163567 | Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163567 | PubMed |
| 34478517 | Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma. | Blood Adv | 2021 | https://conductscience.org/library/papers/34478517 | PubMed |
| 34151200 | Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma. | ACS Pharmacol Transl Sci | 2021 | https://conductscience.org/library/papers/34151200 | PubMed |
| 33860196 | Inhibition of P-Glycoprotein Does Not Increase the Efficacy of Proteasome Inhibitors in Multiple Myeloma Cells. | ACS Pharmacol Transl Sci | 2021 | https://conductscience.org/library/papers/33860196 | PubMed |
| 33543229 | Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers. | Biosci Rep | 2021 | https://conductscience.org/library/papers/33543229 | PubMed |
| 33053111 | P-glycoprotein associated with diabetes mellitus and survival of patients with pancreatic cancer: 8-year follow-up. | Braz J Med Biol Res | 2020 | https://conductscience.org/library/papers/33053111 | PubMed |
| 32170169 | A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma. | Blood Cancer J | 2020 | https://conductscience.org/library/papers/32170169 | PubMed |
| 32050631 | Multiple Myeloma: Available Therapies and Causes of Drug Resistance. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32050631 | PubMed |
| 31620167 | Treatment May Be Harmful: Mechanisms/Prediction/Prevention of Drug-Induced DNA Damage and Repair in Multiple Myeloma. | Front Genet | 2019 | https://conductscience.org/library/papers/31620167 | PubMed |
| 31121280 | Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors. | J Control Release | 2019 | https://conductscience.org/library/papers/31121280 | PubMed |
| 30140376 | STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models. | Oncotarget | 2018 | https://conductscience.org/library/papers/30140376 | PubMed |
| 29766327 | Characterization of carfilzomib-resistant non-small cell lung cancer cell lines. | J Cancer Res Clin Oncol | 2018 | https://conductscience.org/library/papers/29766327 | PubMed |
| 29181307 | Expression of multidrug resistance proteins in retinoblastoma. | Int J Ophthalmol | 2017 | https://conductscience.org/library/papers/29181307 | PubMed |
| 28509582 | Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance. | Leuk Lymphoma | 2017 | https://conductscience.org/library/papers/28509582 | PubMed |
| 28203307 | Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma. | Clin Epigenetics | 2017 | https://conductscience.org/library/papers/28203307 | PubMed |
| 27648351 | Disrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter? | Am J Cancer Res | 2016 | https://conductscience.org/library/papers/27648351 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8093668
GET https://conductscience.org/api/papers/v1/8093668/cited_by?page=2